Foregut Dysmotility in the Lung Transplant Patient

2021 ◽  
Vol 23 (12) ◽  
Author(s):  
Danny Wong ◽  
Walter W. Chan
2021 ◽  
Vol 21 (3) ◽  
pp. 1340-1342
Author(s):  
Abbas Shahmohammadi ◽  
Martin Rosenthal ◽  
Mauricio Pipkin ◽  
Tiago N. Machuca

2021 ◽  
Vol 36 (1) ◽  
pp. 34-41
Author(s):  
Lia Argevani ◽  
Michael J. Schuh ◽  
Sheena Crosby

Objective: To report pharmacogenomics post-related bradykinesia secondary to phenoconversion in an elderly post-bilateral lung transplant patient. Summary: The patient was a 68-year-old double lung transplant patient taking the immunosuppressant and CYP3A4/5 substrate tacrolimus concomitantly with 2 CYP3A4/5 inhibitor medications, fluconazole and diltiazem. This drug combination post-dosing resulted in debilitating bradykinesia 1-2 hours after dosing, increasing the risk of falls and possible increased mortality and morbidity risk. Conclusion: Taking tacrolimus in combination with CYP3A4/5 inhibitors may increase neurologic adverse effects resulting in increased fall and associated increased mortality and morbidity risk.


2005 ◽  
Vol 129 (8) ◽  
pp. 976-976
Author(s):  
Amir Kazory ◽  
Didier Ducloux

2001 ◽  
Vol 20 (3) ◽  
pp. 288-296 ◽  
Author(s):  
Janet Madill ◽  
Carlos Gutierrez ◽  
Jennifer Grossman ◽  
Johanne Allard ◽  
Charlie Chan ◽  
...  

2006 ◽  
Vol 54 (4) ◽  
pp. 657-663 ◽  
Author(s):  
Eun Ji Kwon ◽  
Kenneth A. Katz ◽  
Karla S. Draft ◽  
John T. Seykora ◽  
Alain H. Rook ◽  
...  

2005 ◽  
Vol 129 (6) ◽  
pp. e153-e154
Author(s):  
Diana N. Ionescu ◽  
Sanja Dacic

CHEST Journal ◽  
2019 ◽  
Vol 156 (4) ◽  
pp. A1335 ◽  
Author(s):  
Ahmad Aljamal ◽  
Sashi Nair ◽  
Ahmed Elbanna ◽  
alaa abu-sayf

Sign in / Sign up

Export Citation Format

Share Document